Status:
NOT_YET_RECRUITING
Home-based Remote Monitoring
Lead Sponsor:
The University of Hong Kong
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute myocardial infarction (MI) is a disease of high morbidity and mortality. It is usually caused by atherothrombosis of major epicardial coronary arteries which result in myocardial necrosis. Due t...
Detailed Description
This is a prospective, multi-center, open-labelled, randomized controlled trial. Patients with acute myocardial infarction with primary or early percutaneous coronary intervention (PCI) will be recrui...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Hospitalized with acute myocardial infarction as defined as a detection of a rise and/or fall of troponin with at least 1 value above the 99th percentile upper reference limit together with either (1) symptoms of myocardial ischemia, or (2) ECG changes compatible with myocardial ischemia
- Treated with PCI for culprit lesson
- Voluntarily agrees to participate by providing written informed consent
Exclusion
- Complex congenital heart disease
- Significant valvular stenosis
- Left ventricular assist device
- Listed for heart transplant
- Renal impairment with serum creatinine ≥ 190 μmol/L or on renal replacement therapy
- Inability or refusal to provide inform consent
- Short life expectance (\< 1 year) due to concomitant medical condition(s)
- Lack of skills in operating simple electronic devices
- Unavailability of a mobile network service in the place of residence
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
344 Patients enrolled
Trial Details
Trial ID
NCT05295303
Start Date
July 1 2022
End Date
June 30 2026
Last Update
March 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong, Queen Mary Hospital
Hong Kong, Hong Kong